OraSure Technologies (NASDAQ: OSUR)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-02 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.280 | ||||||
REV | 67.707M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of OraSure Technologies (NASDAQ: OSUR) through any online brokerage.
Other companies in OraSure Technologies’s space includes: RxSight (NASDAQ:RXST), Meihua International (NASDAQ:MHUA), Meridian Bioscience (NASDAQ:VIVO), BioLife Solns (NASDAQ:BLFS) and Embecta (NASDAQ:EMBC).
The latest price target for OraSure Technologies (NASDAQ: OSUR) was reported by Citigroup on Wednesday, May 11, 2022. The analyst firm set a price target for 10.00 expecting OSUR to rise to within 12 months (a possible 246.02% upside). 5 analyst firms have reported ratings in the last year.
The stock price for OraSure Technologies (NASDAQ: OSUR) is $2.89 last updated June 24, 2022, 8:00 PM UTC.
There are no upcoming dividends for OraSure Technologies.
OraSure Technologies’s Q2 earnings are confirmed for Tuesday, August 2, 2022.
There is no upcoming split for OraSure Technologies.
OraSure Technologies is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.